Blueprint Medicines shares owned by Martingale Asset Management
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Martingale Asset Management
from 13F filings
Historical chart of Martingale Asset Management investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by Martingale Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.3M | 14k | 92.24 |
| 2023-09-30 | $809k | 16k | 50.22 |
| 2023-06-30 | $1.0M | 16k | 63.20 |
| 2023-03-31 | $748k | 17k | 44.99 |
| 2021-12-31 | $1.7M | 16k | 107.16 |
| 2021-09-30 | $2.8M | 27k | 102.82 |
| 2021-06-30 | $1.3M | 14k | 88.00 |
| 2021-03-31 | $449k | 4.6k | 97.41 |
| 2020-12-31 | $394k | 3.5k | 112.35 |
| 2020-09-30 | $844k | 9.1k | 92.72 |
| 2020-06-30 | $820k | 11k | 78.07 |
More positions owned by Martingale Asset Management
View all positions for Martingale Asset Management